Response to letter regarding “Co-radiotherapy with tyrosine kinase inhibitors might benefit survival in hepatoma patients with portal vein tumor thrombosis”
Response to letter regarding “Co-radiotherapy with tyrosine kinase inhibitors might benefit survival in hepatoma patients with portal vein tumor thrombosis”. // Biomedical Journal. – URL: https://www.sciencedirect.com/science/article/pii/S2319417026000715?dgcid=rss_sd_all
Response to letter regarding “Co-radiotherapy with tyrosine kinase inhibitors might benefit survival in hepatoma patients with portal vein tumor thrombosis”. Biomedical Journal. https://www.sciencedirect.com/science/article/pii/S2319417026000715?dgcid=rss_sd_all
“Response to letter regarding “Co-radiotherapy with tyrosine kinase inhibitors might benefit survival in hepatoma patients with portal vein tumor thrombosis”.” Biomedical Journal.
@article{article37878,
title = {Response to letter regarding “Co-radiotherapy with tyrosine kinase inhibitors might benefit survival in hepatoma patients with portal vein tumor thrombosis”},
journal = {Biomedical Journal},
url = {https://www.sciencedirect.com/science/article/pii/S2319417026000715?dgcid=rss_sd_all}
}
ABSTRACT As leadership education continues to evolve, increasing attention has been given to fostering learners’ leadership identity, capacity, and efficacy. Drawing on collaborative conversations with 12 leadership educators...